Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David T W Jones

Showing results (1-10 of 362) with videos related to

Pageof 37
Sort By:
Annual Review of Genetics|December 4, 2019
The Power of Human Cancer Genetics as Revealed by Low-Grade GliomasDavid T W Jones, Pratiti Bandopadhayay, Nada Jabado
Med (New York, N.Y.)|August 13, 2022
Pediatric precision oncology-Time for clinical prime timeStefan M Pfister, Olaf Witt, David T W Jones
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 23, 2017
Pediatric Gliomas: Current Concepts on Diagnosis, Biology, and Clinical ManagementDominik Sturm, Stefan M Pfister, David T W Jones
Acta Neuropathologica|March 21, 2015
Pilocytic astrocytoma: pathology, molecular mechanisms and markersV Peter Collins, David T W Jones, Caterina Giannini
Seminars in Cancer Biology|June 11, 2021
Precision medicine in pediatric solid cancersMirjam Blattner-Johnson, David T W Jones, Elke Pfaff
Cell|April 29, 2014
Connect four with glioblastoma stem cell factorsJan Gronych, Stefan M Pfister, David T W Jones
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2017
BRAF V600E Status Alone Is Not Sufficient as a Prognostic Biomarker in Pediatric Low-Grade GliomaDavid T W Jones, Olaf Witt, Stefan M Pfister
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 1, 2017
New Classification for Central Nervous System Tumors: Implications for Diagnosis and TherapyChristine E Fuller, David T W Jones, Mark W Kieran
The Lancet. Oncology|June 13, 2015
Next-generation (epi)genetic drivers of childhood brain tumours and the outlook for targeted therapiesPaul A Northcott, Stefan M Pfister, David T W Jones
Brain Pathology (Zurich, Switzerland)|February 26, 2013
The role of chromatin remodeling in medulloblastomaDavid T W Jones, Paul A Northcott, Marcel Kool, et al.
Pageof 37

Showing results (1-10 of 362) with videos related to

Sort By:
Pageof 37
Annual Review of Genetics|December 4, 2019
The Power of Human Cancer Genetics as Revealed by Low-Grade GliomasDavid T W Jones, Pratiti Bandopadhayay, Nada Jabado
Med (New York, N.Y.)|August 13, 2022
Pediatric precision oncology-Time for clinical prime timeStefan M Pfister, Olaf Witt, David T W Jones
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 23, 2017
Pediatric Gliomas: Current Concepts on Diagnosis, Biology, and Clinical ManagementDominik Sturm, Stefan M Pfister, David T W Jones
Acta Neuropathologica|March 21, 2015
Pilocytic astrocytoma: pathology, molecular mechanisms and markersV Peter Collins, David T W Jones, Caterina Giannini
Seminars in Cancer Biology|June 11, 2021
Precision medicine in pediatric solid cancersMirjam Blattner-Johnson, David T W Jones, Elke Pfaff
Cell|April 29, 2014
Connect four with glioblastoma stem cell factorsJan Gronych, Stefan M Pfister, David T W Jones
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2017
BRAF V600E Status Alone Is Not Sufficient as a Prognostic Biomarker in Pediatric Low-Grade GliomaDavid T W Jones, Olaf Witt, Stefan M Pfister
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 1, 2017
New Classification for Central Nervous System Tumors: Implications for Diagnosis and TherapyChristine E Fuller, David T W Jones, Mark W Kieran
The Lancet. Oncology|June 13, 2015
Next-generation (epi)genetic drivers of childhood brain tumours and the outlook for targeted therapiesPaul A Northcott, Stefan M Pfister, David T W Jones
Brain Pathology (Zurich, Switzerland)|February 26, 2013
The role of chromatin remodeling in medulloblastomaDavid T W Jones, Paul A Northcott, Marcel Kool, et al.
Pageof 37